Status:
COMPLETED
Sepsis Post Market Clinical Utility Simple Endpoint Study - HUMC
Lead Sponsor:
Beckman Coulter, Inc.
Conditions:
Sepsis
Adult Disease
Eligibility:
All Genders
19-89 years
Brief Summary
The purpose of this study is to demonstrate that addition of the Monocyte Width Distribution (MDW) parameter to current standard of care improves a clinician's ability to recognize sepsis in the Emerg...
Detailed Description
The objective of this study is to develop a method for identifying sepsis patients from electronic health records (EHR) based on Sepsis-2 criteria. Sepsis patients will be identified using a Sepsis De...
Eligibility Criteria
Inclusion
- Adult (18 to 89 years)
- All race and ethnicities
- Presenting to the emergency department with suspicion of infection
- Whose assessment includes a CBC with differential
- Meets EMR Sepsis Definition
Exclusion
- Pregnancy
- Prisoners
- Transfers from other ED
- Previously enrolled
Key Trial Info
Start Date :
September 5 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 6 2022
Estimated Enrollment :
198 Patients enrolled
Trial Details
Trial ID
NCT04804306
Start Date
September 5 2021
End Date
June 6 2022
Last Update
July 18 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hackensack University Medical Center
Hackensack, New Jersey, United States, 07601